0001880794-21-000001.txt : 20210901 0001880794-21-000001.hdr.sgml : 20210901 20210901160859 ACCESSION NUMBER: 0001880794-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 EFFECTIVENESS DATE: 20210901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Attivare Therapeutics, Inc. CENTRAL INDEX KEY: 0001880794 IRS NUMBER: 861598751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-412051 FILM NUMBER: 211230147 BUSINESS ADDRESS: STREET 1: 22 STRATHMORE ROAD CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 22 STRATHMORE ROAD CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0708 D LIVE 0001880794 Attivare Therapeutics, Inc. 22 STRATHMORE ROAD NATICK MA MASSACHUSETTS 01760 000-000-0000 DELAWARE None None Corporation true 2020 Edward Doherty c/o Attivare Therapeutics, Inc. 22 Strathmore Natick MA MASSACHUSETTS 01760 Executive Officer Director Jessica McDonough c/o Attivare Therapeutics, Inc. 22 Strathmore Natick MA MASSACHUSETTS 01760 Director Zeshan Muhammedi c/o Attivare Therapeutics, Inc. 22 Strathmore Natick MA MASSACHUSETTS 01760 Director Joaquim Trias c/o Attivare Therapeutics, Inc. 22 Strathmore Natick MA MASSACHUSETTS 01760 Executive Officer Director Other Decline to Disclose 06b false 2021-08-16 false true true Amount sold includes the conversion of debt and the securities issuable upon conversion. false 0 6325819 4825824 1499995 The amount sold includes convertible debt and the securities issuable upon conversion. false 20 0 0 0 false Attivare Therapeutics, Inc. /s/ Joaquim Trias Joaquim Trias Chief Executive Officer 2021-09-01